AGM
ADMA icon

Alpine Global Management’s ADMA Biologics ADMA Stock Holding History

Alpine Global Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250,000
Closed -$495K – 471
2022
Q2 		$495K Sell
250,000
-29,549
-11% -$58.1K 0.13% 77
2022
Q1 		$512 Buy
279,549
+29,549
+12% +$46.1K 0.12% 98
2021
Q4 		$353K Buy
+250,000
New +$329K 0.05% 426
2021
Q3 		– Sell
-10,645
Closed -$17K – 302
2021
Q2 		$17K Buy
+10,645
New +$18.7K ﹤0.01% 303

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return